REQUEST A DEMO
Total
USD $0.00
Search more companies

Bioray Biotech Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Scientific Research and Development Services
Full name: Bioray Biotech Co., Ltd. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Bioray Biotech Co., Ltd. is focused on the R&D and manufacturing of biological agents. The company provides functional probiotics, medicinal fungi and immune cell preparations. The company was founded in 2005 and its headquarters are located in Kaohsiung City, Taiwan.

Headquarters
No. 21-3, Shennong E. Rd., Changzhi Township
Pingtung County; Pingtung County;

Contact Details: Purchase the Bioray Biotech Co., Ltd. report to view the information.

Website: http://www.bio-ray.com.tm

Basic Information
Total Employees:
Purchase the Bioray Biotech Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Bioray Biotech Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Bioray Biotech Co., Ltd. report to view the information.
Incorporation Date:
March 02, 2005
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
11.24%
Purchase this report to view the information.
9.7%
Purchase this report to view the information.
6.65%
Purchase this report to view the information.
3.46%
Purchase this report to view the information.
0.07%
Subsidiaries
九禾健康科技股份有限公司
100%
千鈺生醫股份有限公司
100%
德和生物科技股份有限公司
100%
Company Performance
Financial values in the chart are available after Bioray Biotech Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-8.79%
Total operating revenue
-5.09%
Operating profit (EBIT)
-21.4%
EBITDA
-94.76%
Net Profit (Loss) for the Period
-70.4%
Total assets
-2.66%
Total equity
-5.11%
Operating Profit Margin (ROS)
-3.57%
Net Profit Margin
-5.56%
Return on Equity (ROE)
-1.09%
Quick Ratio
-0.4%
Cash Ratio
-0.47%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?